MiR-29a is a crucial tumor suppressor in gliomagenesis by forming a negative feedback loop for TRAF4/AKT signaling, inhibits cell proliferation, migration, and invasion, and is an effective candidate for the treatment of glioma (77). Here, TRAF4 is linked to central nervous system cancer.